相关实验视频
Updated: Jun 8, 2025

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
通过非脂质基本激动剂激活强烈的溶解酸受体1的结构机制
Hiroaki Akasaka1, Fumiya K Sano1, Wataru Shihoya2
1Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.
研究人员揭示了非脂质激动剂如何强烈地激活 lysophosphatidic 酸受体 1 (LPA). 与非脂质激动剂结合的LPA1的结构为与LPA1相关的疾病的药物开发提供了洞察力.
科学领域:
- 结构生物学是结构生物学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- lysophosphatidic 酸受体 1 (LPA) 是一种 G 蛋白结合受体,参与各种疾病.
- LPA1激动剂显示出对肥胖和抑郁症的治疗潜力.
- 对LPA1非脂质激动剂激活的机制尚未完全理解.
研究的目的:
- 阐明非脂质激动剂介导的LPA激活的结构基础.
- 提供有关联体识别和受体激活的机制性见解.
- 扩大针对LPA受体的药物开发策略.
主要方法:
- 人类LPA1-Gi复合体的冷电子显微镜 (冷EM).
- 与脂质GPCRs的结构比较.
- 对联体受体相互作用的分析.
主要成果:
- 确定了人体LPA1与强大的非脂质激动剂,CpY.结合的冷-EM结构.
- 确定了关键的结构特征,使得 LPA 的绑定口袋能够选择性地识别 CpY.
- 揭示了CpY如何通过与残留物W2716.48的相互作用来稳定LPA的活性构造.
结论:
- 像CPY这样的非脂质激动剂具有独特的化学特征,对于强大的LPA激活至关重要.
- 这项研究提供了对非脂质激动剂LPA激活的详细机制见解.
- 这些发现有助于开发针对LPA受体的新疗法.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
IP3/DAG Signaling Pathway
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Amplifying Signals via Second Messengers
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
GPCRs Regulate Adenylyl Cylase Activity
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...